DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Marina Repkova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia. Hauptthemen laut MEDLINE: Influenza A Virus, H5N1 Subtype, Oligodeoxyribonucleotides, Polylysine, Antiviral Agents. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian state-funded project for ICBFM SB RAS, State Research Center of Virology and Biotechnology "Vector," Russia.
Abstract (Originalsprache)
The nanocomposites based on aminopropylsilanol (Si~NH 2 ) and polylysine‐anatase (Ans/PL) nanoparticles bearing DNAzymes (Dz) and oligodeoxyribonucleotides (ON) can effectively inhibit the replication of the influenza A/H5N1 virus in cell culture. Nanocomposites based on both types of nanoparticles exhibit high activity. The Dz‐containing nanocomposites exhibited higher antiviral activity than those containing ON, reducing influenza A/H5N1 virus production by 3.5 log versus 2.4–3.0 log, respectively. Notably, the effect of Dz incorporated into the nanoparticles was an order of magnitude higher than that of unbound Dz transfected with lipofectamine. Nanocomposites carrying control DNA fragments that are not specific to the influenza A virus genome have practically no antiviral activity, indicating the specificity of the proposed nanocomposites. It was demonstrated that the antiviral efficacy of the nanocomposites is primarily determined by the activity of DNA delivered into cells, which can be varied by altering either the nanocomposite concentration or its capacity for DNA fragments. All of the proposed nanocomposites can be considered as potential antiviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.
- FBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
ORCID-Profile: Marina Repkova, Asya Levina, Valentina Zarytova
Förderung
- Russian state-funded project for ICBFM SB RAS
- State Research Center of Virology and Biotechnology "Vector," Russia
Zitieren
APA
Repkova, M., Levina, A., Filippova, E., Makarevich, E., Protsenko, M., Shishkina, L., Sergeev, A., & Zarytova, V. (2026). DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70419
Vancouver
Repkova M, Levina A, Filippova E, Makarevich E, Protsenko M, Shishkina L, et al. DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70419
BibTeX
@article{Repkova2026,
author = {Repkova, Marina and Levina, Asya and Filippova, Ekaterina and Makarevich, Elena and Protsenko, Maria and Shishkina, Larisa and Sergeev, Artemiy and Zarytova, Valentina},
title = {DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine‐Anatase Nanoparticles as Active Agents Against Influenza A/ H5N1 Virus},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70419}
}
EUVIMED